Serotonergic and dopaminergic metabolites in cerebrospinal fluid of epileptics. 1982

A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava

UI MeSH Term Description Entries
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
February 2004, Movement disorders : official journal of the Movement Disorder Society,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
January 1958, Acta biologica et medica Germanica,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
October 1982, Neurochemical research,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
January 1951, L'Ospedale psichiatrico,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
March 1985, No to shinkei = Brain and nerve,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
February 1982, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
December 1989, The Journal of pharmacology and experimental therapeutics,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
January 1978, Advances in shock research,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
January 2009, Nordic journal of psychiatry,
A Mohan, and D Nag, and R N Misra, and V R Gujrati, and K Shanker, and D C Doval, and R C Saxena, and K P Bhargava
January 2007, Nordic journal of psychiatry,
Copied contents to your clipboard!